CN1071115C - Compound medicine for gastroenteritis and gastroenteritic ulcer - Google Patents

Compound medicine for gastroenteritis and gastroenteritic ulcer Download PDF

Info

Publication number
CN1071115C
CN1071115C CN98116559A CN98116559A CN1071115C CN 1071115 C CN1071115 C CN 1071115C CN 98116559 A CN98116559 A CN 98116559A CN 98116559 A CN98116559 A CN 98116559A CN 1071115 C CN1071115 C CN 1071115C
Authority
CN
China
Prior art keywords
medicine
compound medicine
gastroenteritis
ulcer
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN98116559A
Other languages
Chinese (zh)
Other versions
CN1205876A (en
Inventor
彭小平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN98116559A priority Critical patent/CN1071115C/en
Publication of CN1205876A publication Critical patent/CN1205876A/en
Application granted granted Critical
Publication of CN1071115C publication Critical patent/CN1071115C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention discloses a compound medicine for treating gastroenteritis and ulcers, which is prepared from furazolidone and vitamin B6 mixed in the portion ratio of (7 to 15): 1 by weight and made into medicament forms, such as tablets, capsules, powder, etc. The compound medicine can treat gastric ulcer, duodenal ulcer, gastric inflammation, duodenal inflammation and chronic enteritis. The present invention has the characteristics of significant curative effects, difficult relapse, no drug dependence generation, sufficient component medicine sources, simple preparation and low cost for raw medicinal materials.

Description

A kind of compound medicines for the treatment of gastroenteritis and ulcer
The present invention relates to a kind of compound recipe Western medicine, relate in particular to a kind of specially good effect Western medicine for the treatment of gastric and duodenal ulcers, stomach and duodenitis, chronic enteritis.
At present the medicine of treatment stomach, enteritis has multiplely, and happy etc. as SANJIU WEITAI, bismuth potassium citrate, beautiful pearl intestinal, its curative effect is very good, but costs an arm and a leg, and its required medication period is long, and from a plurality of cases, recurs easily.Carry the also useful furazolidone of prior art, vitamin B according to patent gazette 6And the gastrointestinal drug that is combined into of plurality of Chinese, clinical experiment shows, to increase, produce preparation complicated to improving the unhelpful and cost of curative effect to add other medicines.
The objective of the invention is to: a kind of good effect is provided, cost is low, preparation is simple, medication period is short and is difficult for treatment stomach, the enteritis compound medicines of recurrence.
Technical scheme of the present invention is: with furazolidone and vitamin B 67~15: 1 mixed is made dosage forms such as tablet powder or capsule then by weight.
Compound medicines of the present invention can be treated gastric and duodenal ulcers, stomach and duodenitis, chronic enteritis; has the treatment outstanding feature; except that special case, normal case all can be fully recovered after taking medicine 5~7 days, and is difficult for recurrence; can not produce drug dependence; with each component medicine source abundance, preparation is simple, and the crude drug cost is extremely low; be no more than 1 yuan 5 jiaos by the existing valency full course of treatment (5~7 days) crude drug cost, can be made into multiple dosage forms such as tablet, capsule grain or powder.
The present invention is described in detail below in conjunction with embodiment.
Embodiment 1:
Earlier with 9 kilograms of furazolidone and vitamin B 61 kilogram of mixing is made the tablet of 110 milligrams of every tablet qualities then.
Embodiment 2:
With 8 kilograms of furazolidone and vitamin B 60.8 the kilogram mixing is made every quality and is 100 milligrams capsule again.
Embodiment 3:
With 13 kilograms of furazolidone and vitamin B 61 kilogram of mixing, being distributed into every bag (bag, bottle) quality is 100 milligrams powder.
Below in conjunction with case curative effect of the present invention is described further.Case 1: the patient man, 32 years old, medical history 4-5 took this medicine preabdomen flatulence, acid regurgitation water, stomach pain, sooner or later stronger especially with chest pain, need during seat to withstand stomach with fist or desk drawer.The 4th day gastric gas of taking medicine begins to stir, and the rumble sound is arranged, and it is much more comfortable to stir back patient's gastric, and flatulence obviously alleviates, and stomachache is basic after taking medicine 5 days disappears, other symptom complete obiteration, total 6 days courses of treatment.Not recurrence in 12 years.Treatment is had a dizzy spell after 12 years, and clothes NAOLIQING pill 7 days, and clothes are during to the 3rd day, and gastric is felt to have like skin and frayed the same pain of skin, after 7 days, and acid regurgitation water, stomachache heavy (alleviating after the food).It is the same that stomach seemingly is suspended in intraperitoneal, can slow down slightly soon by bike, will pass through gently when crossing uneven road surface, one jolts slightly, and the sensation stomach obviously drops, and feels bad very much, obeys and fully recovers behind the medicine in 6 days.Case 2: the patient man, 48 years old, the village doctor, medical history more than ten years, obey multiple in, Western medicine all do not have positive effect.Take this medicine front lip pastiness, stomachache is heavy, especially with the fierceness at midnight, can not fall asleep, and crys, once examination in hospital: pyloric ostium of stomach and duodenal ulcer.Take this medicine to second day pain and disappear substantially, took medicine 7 days.Take medicine and finish one week of back transference cure.The complexion remarkable improvement.Case 3: patient woman, 38 years old, the workman, medical history 3 years, once examination in hospital was diagnosed as superficial gastritis, after suffer from chronic enteritis again, obeyed the multiple gastroenteritis medicine of controlling as bismuth aluminate compound, SANJIU WEITAI etc., effect is not bad when just obeying, and recurs again but cross some months.Before obeying this compound medicines, stomach is often sore, and morning or the back pain of catching cold are heavy, frequent diarrhoea, eat living Bulbus Allii after diarrhoea take a turn for the better, stomach again pain more severe, take this medicine to the 4th day various symptoms and disappear substantially, took medicine recovery from illness altogether 5 days.

Claims (1)

1, a kind of compound medicines for the treatment of gastroenteritis and ulcer is characterized in that: by furazolidone and vitamin B 67~15: 1 proportioning is composited by weight.
CN98116559A 1998-08-07 1998-08-07 Compound medicine for gastroenteritis and gastroenteritic ulcer Expired - Fee Related CN1071115C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN98116559A CN1071115C (en) 1998-08-07 1998-08-07 Compound medicine for gastroenteritis and gastroenteritic ulcer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN98116559A CN1071115C (en) 1998-08-07 1998-08-07 Compound medicine for gastroenteritis and gastroenteritic ulcer

Publications (2)

Publication Number Publication Date
CN1205876A CN1205876A (en) 1999-01-27
CN1071115C true CN1071115C (en) 2001-09-19

Family

ID=5225145

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98116559A Expired - Fee Related CN1071115C (en) 1998-08-07 1998-08-07 Compound medicine for gastroenteritis and gastroenteritic ulcer

Country Status (1)

Country Link
CN (1) CN1071115C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
CN101947224B (en) * 2010-09-29 2012-04-25 封勇刚 Stomach medicine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1136960A (en) * 1989-04-28 1996-12-04 美国辉瑞有限公司 Polyamines and polypeptides useful as antagonisis of excitatory amino acid neurotransmitiers and/or as blockers of calcium channels

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1136960A (en) * 1989-04-28 1996-12-04 美国辉瑞有限公司 Polyamines and polypeptides useful as antagonisis of excitatory amino acid neurotransmitiers and/or as blockers of calcium channels

Also Published As

Publication number Publication date
CN1205876A (en) 1999-01-27

Similar Documents

Publication Publication Date Title
CN102106360B (en) Sucrose-free prebiotic biscuits with function of nursing stomach illness and preparation method thereof
CN100435831C (en) Preparation for treating high blood pressure, high blood fat, obesity, and climacteric syndrome, and preparation method
Kumar et al. Controlled therapeutic trial to determine the optimum dose of antacids in duodenal ulcer.
KR0145715B1 (en) N-acetyl glucosamine as a cytoprotective agent
CA1207239A (en) Gastrointestinal compositions
McElroy et al. Treatment of panic disorder and benzodiazepine withdrawal with valproate
CN101607036B (en) Application of Chinese medicinal composition on in preparing medicament for treating depression
CN1071115C (en) Compound medicine for gastroenteritis and gastroenteritic ulcer
CN102125660A (en) Traditional Chinese medicine sustained-release micro granules stomach and intestine partner for protecting and strengthening functions of stomach and intestine
CN101590031B (en) preparation method of disodium sulfodehydroabietate (DSDA) and composition
CN1706433A (en) Chinese medicine composition for treating gastrointestinal diseases
CN101112490A (en) Medicine for treating chronic atrophic gastritis
CN108853376A (en) The medicine for external application and preparation method thereof for treating canker sore
CN111000243A (en) Application of composition of oligosaccharide and lactein in food and health products
CN100337681C (en) Gastric ulcer treating medicine
CN101204400A (en) Prescripton and preparing method of colla corii asini line products
CN1089591C (en) Medical powder or capsule for treating gastropathies
CN109453331B (en) Traditional Chinese medicine composition for treating gastric ulcer
CN1118286C (en) Specific oral liquid for treating various gastroenteristic diseases and its preparation
Blake et al. Management of hypertension: Useful nonpharmacologic measures
DEJoNc PAUL B. HOEBER, INC.
CN1043958C (en) Traditional Chinese medicinal liquor for treatment of stomach trouble
CN118105452A (en) Traditional Chinese medicine composition for assisting in controlling blood sugar and preparation method and application thereof
CN1300613A (en) Process for preparing 'Weilinsan'
CN1136950A (en) Medicinal composition for curing ulcer and inflammation of gastro-intestinal tract and producing process thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee